DGAP-News
Celesio AG: Celesio announces results for short fiscal year 2015 - Seite 3
Earnings per share EUR 0.22 -1.10 /
(basic)
1) Adjusted for special effects from defined non-recurring expenses and
income (including tax effect).
2) Closing figures as at 31 December/31 March.
3) Closing figures at the end of the reporting period.
4) Based on EBITDA of the last twelve months.
5) Previous year figures as reported.
Press Contact
Marc Binder, Celesio AG, +49 (0) 711.5001-380
media@celesio.com
Rainer Berghausen, Celesio AG, +49 (0) 711.5001-549
media@celesio.com
Investor Relations
Michael Otto, Celesio AG, +49 (0) 711.5001-635
investor@celesio.com
Creditor Relations
Tobias Mommertz, Celesio AG, +49 (0) 711.5001-395
finance@celesio.com
About the Celesio Group
Celesio is a leading international wholesale and retail company and
provider of logistics and services to the pharmaceutical and healthcare
sectors. The proactive and preventive approach ensures that patients
receive the products and support that they require for optimum care. With
more than 38,000 employees, Celesio operates in 14 countries around the
world. Every day, the group serves over 2 million customers - at about
2,200 pharmacies of its own and over 4,300 participants in brand
partnership schemes. With 133 wholesale branches, Celesio supplies 65,000
pharmacies and hospitals every day with up to 130,000 pharmaceutical
products. The services benefit a patient pool of about 15 million per day.
McKesson Corporation, San Francisco, USA, is the majority shareholder in
Celesio AG. The company acquired more than 75 percent of Celesio AG shares
in February 2014. McKesson provides solutions that include pharmaceutical
and medical-surgical supply management, healthcare information technology,
and business and clinical services.
---------------------------------------------------------------------
17.06.2015 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: Celesio AG
Neckartalstr. 155
70376 Stuttgart
Germany
Phone: +49 (0)711 5001-735
Fax: +49 (0)711 5001-740
E-mail: investor@celesio.com
Internet: www.celesio.com
ISIN: DE000CLS1001
WKN: CLS100
Indices: MDAX
Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime
Standard), Munich, Stuttgart; Regulated Unofficial Market
in Hamburg, Hanover; Terminbörse EUREX
End of News DGAP News-Service
---------------------------------------------------------------------
369091 17.06.2015
4) Based on EBITDA of the last twelve months.
5) Previous year figures as reported.
Press Contact
Marc Binder, Celesio AG, +49 (0) 711.5001-380
media@celesio.com
Rainer Berghausen, Celesio AG, +49 (0) 711.5001-549
media@celesio.com
Investor Relations
Michael Otto, Celesio AG, +49 (0) 711.5001-635
investor@celesio.com
Creditor Relations
Tobias Mommertz, Celesio AG, +49 (0) 711.5001-395
finance@celesio.com
About the Celesio Group
Celesio is a leading international wholesale and retail company and
provider of logistics and services to the pharmaceutical and healthcare
sectors. The proactive and preventive approach ensures that patients
receive the products and support that they require for optimum care. With
more than 38,000 employees, Celesio operates in 14 countries around the
world. Every day, the group serves over 2 million customers - at about
2,200 pharmacies of its own and over 4,300 participants in brand
partnership schemes. With 133 wholesale branches, Celesio supplies 65,000
pharmacies and hospitals every day with up to 130,000 pharmaceutical
products. The services benefit a patient pool of about 15 million per day.
McKesson Corporation, San Francisco, USA, is the majority shareholder in
Celesio AG. The company acquired more than 75 percent of Celesio AG shares
in February 2014. McKesson provides solutions that include pharmaceutical
and medical-surgical supply management, healthcare information technology,
and business and clinical services.
---------------------------------------------------------------------
17.06.2015 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: Celesio AG
Neckartalstr. 155
70376 Stuttgart
Germany
Phone: +49 (0)711 5001-735
Fax: +49 (0)711 5001-740
E-mail: investor@celesio.com
Internet: www.celesio.com
ISIN: DE000CLS1001
WKN: CLS100
Indices: MDAX
Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime
Standard), Munich, Stuttgart; Regulated Unofficial Market
in Hamburg, Hanover; Terminbörse EUREX
End of News DGAP News-Service
---------------------------------------------------------------------
369091 17.06.2015
Diskutieren Sie über die enthaltenen Werte
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte